Tetra Pharm Technologies
Tetra Pharm is a research focused biopharmaceutical company delivering cannabinoid based therapies.
| EUR | 2020 | 2021 | 2022 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Tetra Pharm Technologies is a Danish biopharmaceutical startup, established in 2018 and based north of Copenhagen. The company specializes in the development and manufacturing of pharmaceutical drugs that target the endocannabinoid system. These drugs are primarily aimed at treating neuropathic pain, neurological diseases, and mental health disorders.
Tetra Pharm operates in the pharmaceutical industry, specifically within the niche of endocannabinoid system-targeting drugs. This is a relatively new and rapidly evolving field, positioning Tetra Pharm at the forefront of undiscovered territory. The company's primary clients are likely to be healthcare providers and patients suffering from the aforementioned conditions.
The business model of Tetra Pharm is based on research, development, and manufacturing of pharmaceutical drugs. The company generates revenue by selling these drugs to healthcare providers. Additionally, Tetra Pharm is committed to being a sustainable business, indicating a potential focus on environmentally friendly practices in its operations.
In terms of societal impact, Tetra Pharm takes its role seriously. The company is dedicated to improving the quality of life for patients and is conscious of its responsibility to contribute positively to the world.
Keywords: Biopharmaceutical, Danish, Endocannabinoid System, Neuropathic Pain, Neurological Diseases, Mental Health Disorders, Sustainable Business, Pharmaceutical Drugs, Healthcare Providers, Quality of Life.